Myasthaenia Gravis

Explore clinical trials studying Myasthaenia Gravis. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Myasthaenia Gravis trial results

Recruiting

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

NCT06799247

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: A40 Tucson, Arizona, United States

A13 Carlsbad, California, United States

A46 Los Angeles, California, United States

A14 Orange, California, United States

View all 34 locations

View Trial Details

Recruiting

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

NCT07403188

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +36 more
Locations: University of Colorado, Denver Denver, Colorado, United States

View Trial Details

Recruiting

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

NCT06765161

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Clinique Neuro-Outaouais Gatineau, Quebec, Canada

View Trial Details

Recruiting

Myasthenia Gravis Foundation of America Global MG Patient Registry

NCT06617741

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +22 more
Locations: Myasthenia Gravis Foundation of America Westborough, Massachusetts, United States

View Trial Details

Enrolling by Invitation

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

NCT07072676

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +69 more
Locations: Medical Park, Bad Feilnbach, Reithofpark Bad Feilnbach, Germany

View Trial Details

Not Yet Recruiting

Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature

NCT06740656

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brachial Plexus Neuritis, +22 more
Locations: CHRU Nancy Nancy, France

View Trial Details

Not Yet Recruiting

Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)

NCT06684184

Conditions: Myasthaenia Gravis
Locations: Not specified

View Trial Details

Completed

The Evaluation of Belimumab in Myasthenia Gravis (MG)

NCT01480596

Conditions: Myasthaenia Gravis
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Orange, California, United States

GSK Investigational Site Colorado Springs, Colorado, United States

View all 25 locations

View Trial Details

Active, Not Recruiting

Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis

NCT06707727

Conditions: Myasthaenia Gravis
Locations: The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View Trial Details

Myasthaenia Gravis

Myasthaenia Gravis trial results

Related conditions